Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The firm offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The firm conducts its business in one segment, which provides its medical device products to healthcare providers and patients with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. Its surgical pain and recovery products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. Its interventional pain solutions include COOLIEF chronic pain products, OrthogenRx knee osteoarthritis hyaluronic acid (HA) pain relief injection products (GenVisc and TriVisc) and Trident radiofrequency ablation (RFA) products.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
701
701
687
673
820
744
Revenue Growth (YoY)
2%
2%
2%
-18%
10%
4%
Cost of Revenue
347
347
306
293
370
380
Gross Profit
353
353
381
379
450
364
Selling, General & Admin
314
314
314
331
339
300
Research & Development
23
23
26
27
30
32
Operating Expenses
337
337
336
372
374
347
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
-66
-66
-403
-7
65
5
Income Tax Expense
6
6
-17
2
14
0
Net Income
-72
-72
-392
-61
50
5
Net Income Growth
-82%
-82%
543%
-222%
900%
-119%
Shares Outstanding (Diluted)
46.3
46.3
46
46.6
47.3
48.6
Shares Change (YoY)
1%
1%
-1%
-1%
-3%
2%
EPS (Diluted)
-1.57
-1.57
-8.52
-1.32
1.07
0.11
EPS Growth
-82%
-82%
545%
-223%
873%
-119%
Free Cash Flow
43
43
82
14
71
66
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
50.35%
50.35%
55.45%
56.31%
54.87%
48.92%
Operating Margin
2.28%
2.28%
6.4%
1.04%
9.26%
2.15%
Profit Margin
-10.27%
-10.27%
-57.05%
-9.06%
6.09%
0.67%
Free Cash Flow Margin
6.13%
6.13%
11.93%
2.08%
8.65%
8.87%
EBITDA
54
54
89
53
123
54
EBITDA Margin
7.7%
7.7%
12.95%
7.87%
15%
7.25%
D&A For EBITDA
38
38
45
46
47
38
EBIT
16
16
44
7
76
16
EBIT Margin
2.28%
2.28%
6.4%
1.04%
9.26%
2.15%
Effective Tax Rate
-9.09%
-9.09%
4.21%
-28.57%
21.53%
0%
Follow-Up Questions
What are Avanos Medical Inc's key financial statements?
According to the latest financial statement (Form-10K), Avanos Medical Inc has a total asset of $1,073, Net loss of $-72
What are the key financial ratios for AVNS?
Avanos Medical Inc's Current ratio is 3.63, has a Net margin is -10.27, sales per share of $15.14.
How is Avanos Medical Inc's revenue broken down by segment or geography?
Avanos Medical Inc largest revenue segment is Digestive Health, at a revenue of 396,400,000 in the most earnings release.For geography, North America is the primary market for Avanos Medical Inc, at a revenue of 545,000,000.
Is Avanos Medical Inc profitable?
no, according to the latest financial statements, Avanos Medical Inc has a net loss of $-72
Does Avanos Medical Inc have any liabilities?
yes, Avanos Medical Inc has liability of 295
How many outstanding shares for Avanos Medical Inc?
Avanos Medical Inc has a total outstanding shares of 46.45